Clinica chimica acta; international journal of clinical chemistry · 2026
Transferrin-derived TIBC, a flagged but normal result.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Safran Martin, Corines James, Elkins Matthew, Nasr Michel R, Banki Katalin, Cao Zhimin Tim
Аннотация
BACKGROUND: Total Iron Binding Capacity (TIBC) is routinely used in the diagnosis and management of iron disorders. TIBC can be derived by multiplying transferrin value by a conversion factor. Usage of different conversion factors in calculating patient TIBC results and the upper- and lower-limit of TIBC reference intervals inadvertently exist. Its commonality and effect on diagnosis and clinical management remain unknown.
METHODS: Electronic medical records and laboratory operation procedures were examined to identify and analyze the root of cause of discordant patients' results between transferrin and transferrin-derived TIBC. Internet-searching was conducted for the information, posted on-line by 21 randomly selected CLIA-certified clinical laboratories in the USA, on the conversion factors for calculation of the lower- and upper-limit of TIBC reference intervals.
RESULTS: Discordance between the transferrin and transferrin-derived TIBC results were found to cause no adverse impact on quality of patient care. Of the 21 laboratories, 14 (66%) used different conversion factor values ranging 0.74-1.44 for calculating lower-limit of TIBC reference interval, and 1.07-1.42 for the upper limit, with the absolute difference values ranging 0.01-0.67.
CONCLUSION: Our study suggested that usage of different conversion factors in calculating the upper- and lower-limits of TIBC reference intervals be commonly used by the CLIA-regulated clinical laboratories in the USA but remain unnoticed. The phenomenon of discordant results may likely occur to transferrin results near the lower- or upper-limit of reference range and unlikely cause adverse impact on quality of patient care.
METHODS: Electronic medical records and laboratory operation procedures were examined to identify and analyze the root of cause of discordant patients' results between transferrin and transferrin-derived TIBC. Internet-searching was conducted for the information, posted on-line by 21 randomly selected CLIA-certified clinical laboratories in the USA, on the conversion factors for calculation of the lower- and upper-limit of TIBC reference intervals.
RESULTS: Discordance between the transferrin and transferrin-derived TIBC results were found to cause no adverse impact on quality of patient care. Of the 21 laboratories, 14 (66%) used different conversion factor values ranging 0.74-1.44 for calculating lower-limit of TIBC reference interval, and 1.07-1.42 for the upper limit, with the absolute difference values ranging 0.01-0.67.
CONCLUSION: Our study suggested that usage of different conversion factors in calculating the upper- and lower-limits of TIBC reference intervals be commonly used by the CLIA-regulated clinical laboratories in the USA but remain unnoticed. The phenomenon of discordant results may likely occur to transferrin results near the lower- or upper-limit of reference range and unlikely cause adverse impact on quality of patient care.